Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-4896.5%
operating margin TTM
-4992.86%
revenue TTM
588.29 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -0.38 |
| peg ratio | -0.00 |
| price to book ratio | 0.54 |
| price to sales ratio | 18.41 |
| enterprise value multiple | -0.94 |
| price fair value | 0.54 |
profitability ratios | |
|---|---|
| gross profit margin | 84.19% |
| operating profit margin | -4992.86% |
| pretax profit margin | -4909.42% |
| net profit margin | -4896.5% |
| return on assets | -108.63% |
| return on equity | -86.34% |
| return on capital employed | -143.29% |
liquidity ratio | |
|---|---|
| current ratio | 3.29 |
| quick ratio | 3.10 |
| cash ratio | 2.62 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 4,611.63 |
| operating cycle | 4,611.63 |
| days of payables outstanding | 2,835.77 |
| cash conversion cycle | 1,775.87 |
| receivables turnover | 0.00 |
| payables turnover | 0.13 |
| inventory turnover | 0.08 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -386.51 |
| cash flow to debt ratio | -56.02 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.42 |
| cash per share | 0.27 |
| operating cash flow per share | -0.41 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -56.02 |
| short term coverage ratios | -56.02 |
| capital expenditure coverage ratio | -38.91 |
Frequently Asked Questions
When was the last time Vascular Biogenics Ltd. (NASDAQ:VBLT) reported earnings?
Vascular Biogenics Ltd. (VBLT) published its most recent earnings results on 14-08-2023.
What is Vascular Biogenics Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vascular Biogenics Ltd. (NASDAQ:VBLT)'s trailing twelve months ROE is -86.34%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vascular Biogenics Ltd. (VBLT) currently has a ROA of -108.63%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VBLT's net profit margin stand at?
VBLT reported a profit margin of -4896.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VBLT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.29 in the most recent quarter. The quick ratio stood at 3.10, with a Debt/Eq ratio of 0.03.